Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Information on the Expected Conclusion of the Commissioning Agreement for the Medicine Kapruvia (Difelikephalin)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Ustekinumab (Atc Code According to Who: L04ac05)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Lipegfilgrastim (Atc Code According to Who: L03aa14)

Framework Agreement for the Supply of Lenses, Visco-Elastic Product and Customer Packs for the Az Jan Palfijn Hospital Ghent.

Prior Information Notice: 2527 Antineovaskularizing Agents

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Betamethasone and Calcipotriol in all Dosage Forms, with the Exception of Ointment...

Dialogue Conference: Instruments and Reagents for Rapid Nucleic Acid Amplification Tests (Naat) Helse Møre Og Romsdal Hf (Snr)

Delivery of Medical and Laboratory Goods for the Needs of Sia "Jūrmalas Slimnīca" Ii

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/S/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Prostate Fusion Biopsy Device